Why Does Accutane Cause Joint and Muscle Pain?

Isotretinoin, widely known by its former brand name Accutane, causes joint and muscle pain through several overlapping pathways that damage or irritate musculoskeletal tissues. The drug interferes with cartilage maintenance, makes muscle fibers more prone to breakdown, disrupts vitamin D metabolism, and weakens tendons. Roughly half of all patients on isotretinoin develop some form of musculoskeletal complaint, making it one of the drug’s most common side-effect categories after dry skin and chapped lips.

How Common Is the Pain, and Where Does It Show Up?

The musculoskeletal side effects of isotretinoin are not rare or marginal. In a cross-sectional study of 200 acne patients on the drug, about half developed musculoskeletal symptoms during treatment. Back pain was the single most frequent complaint, reported by nearly four out of five symptomatic patients, with about 60% of those cases classified as inflammatory rather than mechanical in nature. Joint pain and muscle pain followed, along with a small number of cases involving inflammation at the sacroiliac joint and tendon insertion points.¹ A systematic review pulling together 13 analytical studies found back pain rates ranging from 41% to 74% across different patient groups, with muscle and joint pain consistently among the top complaints.²

An analysis of the FDA’s adverse event reporting system identified 30 distinct musculoskeletal signals linked to isotretinoin. Joint pain led the count with over 2,400 reports, followed by back pain, muscle pain, arthritis, and sacroiliitis.³ So this is not a niche concern: if you are taking or considering isotretinoin for acne, there is a real chance you will feel something in your joints or muscles during treatment.

What Isotretinoin Does to Cartilage

One of the better-understood pathways involves cartilage, the smooth cushioning tissue that lines the ends of bones inside joints. Isotretinoin is a derivative of vitamin A, and vitamin A derivatives have well-documented inhibitory effects on cartilage cells. They slow down the proliferation of chondrocytes (the cells that maintain cartilage), reduce collagen production, and accelerate the loss of glycosaminoglycans and proteoglycans, two groups of molecules that give cartilage its spongy, shock-absorbing quality.⁴

Think of cartilage as a water-retaining cushion. When the molecules that hold water inside it get stripped away, the cushion loses resilience. Joints start to ache, feel stiff, or protest during movement. The same research group found that acne patients using isotretinoin developed measurably thicker femoral cartilage, which sounds counterintuitive until you realize that cartilage swelling is actually an early sign of degeneration, not health. It is the tissue’s distress response: water distribution changes, structure loosens, and the cartilage becomes less functional even as it puffs up on imaging.

Why Muscles Hurt and Creatine Kinase Spikes

Muscle pain on isotretinoin is linked to direct muscle cell damage, which can be measured through blood levels of creatine kinase (CK), an enzyme that leaks out of injured muscle fibers. Elevated CK has been reported in roughly 16% to 51% of isotretinoin patients, a remarkably wide range that reflects differences in how intensely people exercise while on the drug.⁵

Most of these elevations are mild and go unnoticed, but occasionally the numbers climb high enough to signal real trouble. The proposed mechanisms include increased susceptibility of muscle cell membranes to damage, oxidative stress inside muscle fibers, and disruption of mitochondrial function. Researchers have pointed to retinoid-related apoptotic signaling as a possible trigger, though direct mechanistic evidence in humans remains limited. What is clear is that the muscle injury is measurable and dose-related, not just a subjective complaint.

The Exercise Connection

One of the more striking findings in this area is a synergy between isotretinoin and physical activity. Exercise alone raises CK modestly, which is normal. Isotretinoin alone can raise it as well. But combining the two sometimes produces CK elevations far beyond what either would cause independently. Researchers documented patients whose CK levels were normal on exercise alone and normal on isotretinoin alone, yet spiked dramatically when the two overlapped.⁶ This suggests the drug primes muscle fibers for damage in a way that only becomes apparent when physical stress is added.

In rare cases, this synergy escalates to rhabdomyolysis, a serious condition in which large amounts of muscle protein flood the bloodstream and can damage the kidneys. Case reports describe patients, typically young and otherwise healthy, who developed rhabdomyolysis within months of starting isotretinoin while maintaining their exercise routines.⁷ One documented case involved CK levels reaching 7,325 U/L in a symptomatic teenager, and another involved an asymptomatic patient whose levels hit 35,000 U/L, well into the danger zone, before isotretinoin was even started.⁸

The practical takeaway is not that you must stop exercising on isotretinoin, but that you should pay attention. Unexplained muscle soreness, dark urine, or weakness that feels disproportionate to your workout warrants a CK check. Many dermatologists do not routinely monitor CK unless patients report symptoms, so you may need to bring it up. In one large series, fewer than 2% of patients had CK values above 5,000 IU/L, and most of those had done vigorous exercise or received an intramuscular injection shortly before the blood draw.⁵

Sacroiliitis and Inflammatory Back Pain

Among the more troubling musculoskeletal complications is sacroiliitis, inflammation of the sacroiliac joints at the base of the spine where the pelvis meets the backbone. Sacroiliitis causes deep, aching low back and hip pain that is characteristically worse after rest and improves with movement. It tends to show up on MRI as bone marrow edema, a telltale sign of active inflammation in the joint.

In a pooled analysis of 67 patients who developed isotretinoin-associated sacroiliitis, the median onset was about two and a half months after starting the drug. Low back pain was the leading symptom, reported in about 70% of cases, followed by hip pain in roughly 45%. MRI confirmed sacroiliitis in about three-quarters of the patients. After stopping isotretinoin and treating with anti-inflammatory drugs (and, in some cases, biologic therapy), both symptoms and imaging findings improved.⁹

Sacroiliitis on isotretinoin is not common in absolute terms. Studies estimate it affects somewhere between 4% and 12% of isotretinoin users, depending on how aggressively it is screened for.¹ ¹⁰ But it has one of the strongest disproportionality signals in the FDA adverse event database, meaning it is reported far more frequently with isotretinoin than with other drugs.³ Nine cases presented in one Turkish case series all resolved after stopping the drug and taking NSAIDs.¹¹ The reversibility is reassuring, but the pain can be severe enough during active treatment to interfere with daily life.

What Happens to Tendons

Tendons connect muscle to bone, and they are not spared. An animal study found that isotretinoin caused measurable deterioration in the Achilles tendon of rats. Tendons from treated animals showed significantly more disorganization and degeneration under the microscope compared to controls. And the damage was not just cosmetic: biomechanical testing showed the treated tendons were weaker and less elastic, requiring less force to fail.¹²

Tendinopathy in humans on isotretinoin is less well documented than joint or muscle pain, showing up in clinical studies at rates around 4% to 5%.¹⁰ But the animal data suggest a plausible mechanism: retinoids disrupt the collagen matrix that gives tendons their strength, making them more vulnerable to repetitive strain. If you develop persistent pain at a tendon insertion point, such as the back of your heel or the outside of your elbow, while on isotretinoin, it is worth considering the drug as a contributing factor.

Vitamin D Disruption and Bone Loss

Isotretinoin also alters vitamin D metabolism, which creates a secondary pathway for bone and joint problems. A prospective study of acne patients found that after three months of treatment, levels of 25-hydroxy vitamin D (the main circulating form) and serum calcium both dropped significantly, while markers of bone breakdown increased.¹³

In women who were already vitamin D deficient before starting isotretinoin, the consequences were more pronounced. A preliminary study in this group found that bone mineral density decreased at all measured sites during treatment, with a statistically significant drop of about 5% at the femur. A marker of bone resorption called TRACP rose significantly as well, suggesting that bone was being broken down faster than it was being rebuilt.¹⁴ The authors recommended correcting vitamin D deficiency before starting isotretinoin therapy, a precaution that many prescribers still overlook.

The vitamin D angle matters because low vitamin D is already extremely common in the demographic most likely to take isotretinoin: young people who may spend most of their time indoors. If you are starting a course of the drug, asking your doctor to check your vitamin D level beforehand is a low-cost, low-risk step that could reduce your bone and joint symptoms.

Does the Dose Matter?

Yes, and this is one of the more consistent findings across studies. Higher cumulative doses of isotretinoin are associated with more severe musculoskeletal symptoms. In one study, patients with moderate to severe back pain had received significantly higher cumulative doses than those with only mild pain.¹ Another study found that the median total cumulative dose was significantly higher in patients who developed low back pain than in those who did not.¹⁰

Interestingly, age also plays a role. One study found that pain severity scores correlated with patient age, with older patients within the typical treatment range reporting worse symptoms.¹ Body mass index, on the other hand, did not appear to make a difference. This suggests the dose-related damage is a direct pharmacological effect rather than something mediated by body composition or fat distribution of the drug.

Growth Plate Risks in Younger Patients

There is a separate and more worrying concern for patients whose bones are still growing. Isotretinoin has been linked to premature closure of growth plates, the cartilage zones near the ends of long bones where new bone growth occurs during childhood and adolescence. A literature review found that growth plate problems tend to be associated with higher doses over longer durations, and that the proximal tibia and distal femur (the knee area) seem particularly vulnerable.¹⁵ The strongest signal for premature epiphyseal fusion appeared in the FDA adverse event database as well, where it had the highest disproportionality signal of any musculoskeletal event linked to isotretinoin.³

Most reported cases of premature epiphyseal closure come from patients on high-dose isotretinoin for conditions other than acne, such as neuroblastoma, where the doses used are much higher. But there have been documented cases at the lower therapeutic doses used for acne.¹⁵ In adults whose growth plates have already fused, the concern shifts instead to hyperostosis, an abnormal thickening of bone that can develop with prolonged retinoid exposure.¹⁶

Nerve Sensitivity and Unusual Pain Patterns

Not all pain on isotretinoin fits neatly into the “joints and muscles” box. A preliminary study of nerve function in isotretinoin patients found abnormal neurophysiological findings consistent with a distal, sensory-predominant polyneuropathy, meaning the drug appeared to affect sensory nerves, especially those farther from the spinal cord.¹⁷ This could account for some of the tingling, burning, or diffuse aching that patients describe but that does not correspond to any particular joint or muscle group.

This finding is still preliminary, and large-scale studies on isotretinoin and peripheral nerves have not been done. But it is worth keeping in mind if you experience unusual sensory symptoms during treatment. Not every odd sensation is “just in your head,” and the drug’s reach extends beyond the tissues people usually think about.

SAPHO Syndrome and Rarer Complications

Deep in the FDA adverse event data, some of the strongest signals for isotretinoin involve conditions most people have never heard of. SAPHO syndrome, which involves inflammation of bone, joints, and skin, had the second-highest disproportionality ratio among musculoskeletal events, exceeded only by premature growth plate fusion. Ligament calcification, where soft connective tissue gradually turns to bone-like material, also appeared with a notably strong signal.³ These are rare events, and disproportionality in an adverse event database does not prove the drug caused them. But the pattern reinforces a broader point: isotretinoin does not just cause generic aches. It interacts with bone, cartilage, tendon, and ligament biology in ways that can produce a surprisingly wide range of musculoskeletal problems, from everyday stiffness to conditions that mimic rheumatic diseases.

If you develop persistent or worsening joint symptoms that do not match the typical pattern of mild achiness and back stiffness, a rheumatologic evaluation is reasonable. Several of the case series in the literature describe patients initially thought to have early rheumatic disease whose symptoms resolved completely once the drug was stopped, saving them from unnecessary long-term immunosuppression.

1
PubMed Central. Evaluation of musculoskeletal adverse effects in patients on systemic isotretinoin treatment: A cross-sectional study
2
PubMed Central. Isotretinoin musculoskeletal side effects: a systematic review
3
PubMed Central. Sex- and age-specific musculoskeletal adverse events of isotretinoin: disproportionality analysis of the FAERS database combined with a clinical case series
4
PubMed Central. Increased femoral cartilage thickness in acne patients using isotretinoin: could it be a sign of early osteoarthritis?
5
Acta Dermato-Venereologica. Clinical significance of markedly elevated serum creatine kinase levels in patients with acne on isotretinoin
6
PubMed Central. Elevated creatine kinase levels, exercise, and isotretinoin for acne
7
PubMed Central. Rhabdomyolysis Caused by Isotretinoin and Exercise in an Otherwise Healthy Female Patient
8
PubMed Central. Isotretinoin Associated Rhabdomyolysis: Monitoring Creatine Kinase and Educating Patients
9
PubMed Central. Clinical features, treatment, and outcome of isotretinoin-associated sacroiliitis
10
PubMed Central. Analysis of musculoskeletal side effects of oral Isotretinoin treatment: a cross-sectional study
11
PubMed Central. Sacroiliitis during isotretinoin treatment: Causal association or coincidence?
12
PubMed Central. Isotretinoin induced achilles tendinopathy: Histopathological and biomechanical evaluation on rats
13
PubMed. Does isotretinoin have effect on vitamin D physiology and bone metabolism in acne patients?
14
International Journal of Diabetes and Metabolism. Effects of isotretinoin on bone turnover markers and bone mineral density in women with acne vulgaris and vitamin D deficiency: a preliminary study
15
PubMed. Analysis of the effects of isotretinoin on the premature epiphyseal closure in pediatric populations: a literature review
16
Journal of the American Academy of Dermatology. Isotretinoin effects on bone
17
PubMed. Effects of oral isotretinoin therapy on peripheral nerve functions: a preliminary study